Last reviewed · How we verify
Citrobacter Complicated UTI
Approved treatments
- Ramycin
Fusidic acid works by inhibiting the function of the bacterial ribosome, preventing the production of essential proteins. - Tobi · Novartis
- Vantobra · Pfizer
- Nebcin · University Hospital, Lille
- Noroxin
- Floxin
- Ofloxacine · Assistance Publique - Hôpitaux de Paris
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Citrobacter Complicated UTI patent landscape — cliff calendar, originator estates, attackable patents
- Citrobacter Complicated UTI treatment landscape brief
- Citrobacter Complicated UTI treatment updates RSS
Frequently asked questions about Citrobacter Complicated UTI
What drugs treat Citrobacter Complicated UTI?
Tracked treatments include Ramycin, Tobi, Vantobra, Nebcin, Noroxin, Floxin, Ofloxacine.
What is the treatment for Citrobacter Complicated UTI?
Standard treatment for Citrobacter Complicated UTI includes Ramycin, Tobi, Vantobra, Nebcin, Noroxin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Citrobacter Complicated UTI patent cliff · Citrobacter Complicated UTI CI report
- Treatment: Ramycin
- Treatment: Tobi · Novartis
- Treatment: Vantobra · Pfizer
- Treatment: Nebcin · University Hospital, Lille
- Treatment: Noroxin
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing